Anti-cancer drugs known as kinase inhibitors have often been used in the treatment of pleural mesothelioma and many other cancers. The drugs attack the protein kinases in an effort to prevent cell division and to kill the cancerous cells. Now, researchers report they have found that an investigative drug can effectively shrink tumors in patients with lung cancer and other difficult to treat cancers with a specific kinase. Pleural mesothelioma patients could benefit as well. According to researchers from The University of Texas MD Anderson Cancer Center, in the first-in-human study of the investigational, oral drug BLU-667, “the drug appears […]
The post Drug Targeting Specific Protein Could Lead to Personalized Mesothelioma Treatment appeared first on MesotheliomaHelp.org.
from Blog – MesotheliomaHelp.org https://ift.tt/2qSzeNC
via IFTTT
No comments: